Study of Local Periodontal Regeneration of Chronic Periodontal Disease Patients Receiving Allogeneic Human Dental Pulp Stem Cells Injection Therapy
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Periodontal Diseases
- Sponsor
- Songlin Wang
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Change from Baseline alveolar bone volume examined by computed tomography(CT) at 1 year
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the safety of clinical injection of allogeneic human dental pulp stem cell(DPSC) in local infected periodontal tissue and determine whether injection of allogeneic DPSC is a effective way in the treatment of chronic periodontal disease.
Detailed Description
This study will involve 40 patients who were diagnosed as chronic periodontitis will receive periodontal scaling and root planing. Patients will randomly be divided at the base line into two groups.In test group, 20 chronic periodontitis patients will be treated using local DPSC injection. Whereas, a control group will contain 20 patients who will be treated using placebo. Clinical examination including Quigley-Hein plaque index (QHI), bleeding on probing (BoP), probing depth (PD), clinical attachment level (CAL), and gingival recession (GR) will be perform in different time points during the study. Radiographic and clinical examination will be carried out during the late healing phase up to 12 months post operation.
Investigators
Songlin Wang
Professor and Vice President of Capital Medical University
Capital Medical University
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of periodontal disease will be based on clinical assessment of:
- •Quigley-Hein index (QHI)
- •Bleeding on Probing (BoP)
- •Pocket Probing Depth (PD)
- •gingival recession (GR)
- •Clinical Attachment Level (CAL)
- •furcation involvement,and
- •radiographical assessment. All patients at the base line of this study should have been received the initial treatment and reached the qualified level of oral hygiene to be included in the next stage.
Exclusion Criteria
- •Pregnant,
- •immunosuppressed or diabetes patients,
- •patients exhibit gingival hypertrophy,
- •require premedication, and
- •who have been taking systemic anti-inflammatory medications, or
- •have taken antibiotics or
- •received periodontal instrumentation within 6 months prior to the study, will be excluded.
Outcomes
Primary Outcomes
Change from Baseline alveolar bone volume examined by computed tomography(CT) at 1 year
Time Frame: Baseline and 1 year after intervention.
Secondary Outcomes
- Change from Baseline Probing depth (PD) at 1 year(Baseline and 1 year after intervention.)
- Change from Baseline Clinical attachment level (CAL) at 1 year(Baseline and 1 year after intervention)
- Quigley-Hein plaque index (QHI)(Baseline)
- Change from Baseline Bleeding on probing (BoP) at 1 year(Baseline and 1 year after intervention.)